Morten Hansen

1.7k total citations · 1 hit paper
45 papers, 1.2k citations indexed

About

Morten Hansen is a scholar working on Endocrinology, Diabetes and Metabolism, Economics and Econometrics and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Morten Hansen has authored 45 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Endocrinology, Diabetes and Metabolism, 10 papers in Economics and Econometrics and 7 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Morten Hansen's work include Diabetes Treatment and Management (12 papers), Health Systems, Economic Evaluations, Quality of Life (7 papers) and Drug Transport and Resistance Mechanisms (6 papers). Morten Hansen is often cited by papers focused on Diabetes Treatment and Management (12 papers), Health Systems, Economic Evaluations, Quality of Life (7 papers) and Drug Transport and Resistance Mechanisms (6 papers). Morten Hansen collaborates with scholars based in Denmark, United States and Australia. Morten Hansen's co-authors include Filip K. Knop, David P. Sonne, Anton Pottegård, Jesper Hallas, Tina Vilsbøll, Lotte Rasmussen, Daniel Pilsgaard Henriksen, Lene Vestergaard Ravn‐Nielsen, Thomas Buck and Andreas Brønden and has published in prestigious journals such as PLoS ONE, The Journal of Clinical Endocrinology & Metabolism and Cochrane Database of Systematic Reviews.

In The Last Decade

Morten Hansen

42 papers receiving 1.2k citations

Hit Papers

Efficacy and safety of once weekly semaglutide 2·4 mg for... 2024 2026 2025 2024 10 20 30 40 50
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Efficacy and safety of once weekly semaglutide 2·4 mg for weight management in a predominantly east Asian population with overweight or obesity (STEP 7): a double-blind, multicentre, randomised controlled trial
    2024 59 citations Yiming Mu, Freddy G. Eliaschewitz et al. The Lancet Diabetes & Endocrinology profile →

Peers

Morten Hansen
Julien Bezin France
R. Lassalle France
Matthijs L. Becker Netherlands
Amit D. Raval United States
Jonathan Bouchard United States
Antonios Douros Germany
Liberata Sportiello Italy
B.‐E. Wiholm Sweden
Harvey Newnham Australia
Tiffany Peng United States
Julien Bezin France
Morten Hansen
Citations per year, relative to Morten Hansen Morten Hansen (= 1×) peers Julien Bezin

Countries citing papers authored by Morten Hansen

Since Specialization
Citations

This map shows the geographic impact of Morten Hansen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Morten Hansen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Morten Hansen more than expected).

Fields of papers citing papers by Morten Hansen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Morten Hansen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Morten Hansen. The network helps show where Morten Hansen may publish in the future.

Co-authorship network of co-authors of Morten Hansen

This figure shows the co-authorship network connecting the top 25 collaborators of Morten Hansen. A scholar is included among the top collaborators of Morten Hansen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Morten Hansen. Morten Hansen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gabe, M, Astrid Breitschaft, Filip K. Knop, et al.. (2024). Effect of oral semaglutide on energy intake, appetite, control of eating and gastric emptying in adults living with obesity: A randomized controlled trial. Diabetes Obesity and Metabolism. 26(10). 4480–4489. 18 indexed citations
2.
3.
Mu, Yiming, Freddy G. Eliaschewitz, Morten Hansen, et al.. (2024). Efficacy and safety of once weekly semaglutide 2·4 mg for weight management in a predominantly east Asian population with overweight or obesity (STEP 7): a double-blind, multicentre, randomised controlled trial. The Lancet Diabetes & Endocrinology. 12(3). 184–195. 59 indexed citations breakdown →
4.
5.
Kristensen, Kasper Bruun, Lars Christian Lund, Peter Bjødstrup Jensen, et al.. (2022). Development and Validation of a Nordic Multimorbidity Index Based on Hospital Diagnoses and Filled Prescriptions. Clinical Epidemiology. Volume 14. 567–579. 24 indexed citations
6.
Vojdeman, Fie Juhl, Stig Ejdrup Andersen, Troels K. Bergmann, et al.. (2022). DPYD genotyping and dihydropyrimidine dehydrogenase (DPD) phenotyping in clinical oncology. A clinically focused minireview. Basic & Clinical Pharmacology & Toxicology. 131(5). 325–346. 11 indexed citations
7.
Ahmed, Hashim U., Mogens Larsen, Morten Hansen, & Charlotte Uggerhøj Andersen. (2021). The role of QT-prolonging medications in a forensic autopsy study from Western Denmark. Forensic Science International. 325. 110889–110889. 6 indexed citations
8.
Newsome, Philip N., Sven Francque, Stephen A. Harrison, et al.. (2019). Effect of semaglutide on liver enzymes and markers of inflammation in subjects with type 2 diabetes and/or obesity. Alimentary Pharmacology & Therapeutics. 50(2). 193–203. 144 indexed citations
9.
Hansen, Morten, Asbjørn Hróbjartsson, Anton Pottegård, et al.. (2019). Postponement of Death by Statin Use: a Systematic Review and Meta-analysis of Randomized Clinical Trials. Journal of General Internal Medicine. 34(8). 1607–1614. 7 indexed citations
10.
Rasmussen, Lotte, Nicole Pratt, Morten Hansen, Jesper Hallas, & Anton Pottegård. (2018). Using the “proportion of patients covered” and the Kaplan‐Meier survival analysis to describe treatment persistence. Pharmacoepidemiology and Drug Safety. 27(8). 867–871. 42 indexed citations
11.
Sun, Emily, Richard L. Young, Morten Hansen, et al.. (2018). Metformin-induced glucagon-like peptide-1 secretion contributes to the actions of metformin in type 2 diabetes. JCI Insight. 3(23). 130 indexed citations
12.
Rohde, Ulrich, David P. Sonne, Mikkel Christensen, et al.. (2016). Cholecystokinin-Induced Gallbladder Emptying and Metformin Elicit Additive Glucagon-Like Peptide-1 Responses. The Journal of Clinical Endocrinology & Metabolism. 101(5). 2076–2083. 30 indexed citations
13.
Pottegård, Anton, Tore Bjerregaard Stage, Morten Hansen, et al.. (2014). SearCh for humourIstic and Extravagant acroNyms and Thoroughly Inappropriate names For Important Clinical trials (SCIENTIFIC): qualitative and quantitative systematic study. BMJ. 349(dec16 13). g7092–g7092. 8 indexed citations
14.
Hansen, Morten, David P. Sonne, & Filip K. Knop. (2014). Bile Acid Sequestrants: Glucose-Lowering Mechanisms and Efficacy in Type 2 Diabetes. Current Diabetes Reports. 14(5). 482–482. 44 indexed citations
15.
Sonne, David P., Morten Hansen, & Filip K. Knop. (2014). MECHANISMS IN ENDOCRINOLOGY: Bile acid sequestrants in type 2 diabetes: potential effects on GLP1 secretion. European Journal of Endocrinology. 171(2). R47–R65. 59 indexed citations
16.
Hansen, Morten, Jacob Eifer Møller, Lars Videbæk, et al.. (2014). Intracoronary Injection of CD34+-Cells in Chronic Ischemic Heart Failure: 7 Years Follow-Up of the DanCell Study. Cardiology. 129(2). 69–74. 4 indexed citations
17.
Hansen, Morten, David P. Sonne, Stine Ulrik Mikkelsen, et al.. (2012). Effect of bile acid sequestrants on glycaemic control: protocol for a systematic review with meta-analysis of randomised controlled trials. BMJ Open. 2(6). e001803–e001803. 8 indexed citations
18.
Savarimuthu, Thiusius Rajeeth, Morten Hansen, & Lars‐Peter Ellekilde. (2010). Tracking blood vessels in human forearms using visual servoing. University of Southern Denmark Research Portal (University of Southern Denmark). 1–7. 1 indexed citations
19.
20.
Toft, Palle, Lars Heslet, Morten Hansen, & N. A. Klitgaard. (1991). Theophylline and ethylenediamine pharmacokinetics following administration of aminophylline to septic patients with multiorgan failure. Intensive Care Medicine. 17(8). 465–468. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Julien Bezin Breakdown of academic impact, for papers by R. Lassalle Breakdown of academic impact, for papers by Matthijs L. Becker Breakdown of academic impact, for papers by Amit D. Raval Breakdown of academic impact, for papers by Jonathan Bouchard Breakdown of academic impact, for papers by Antonios Douros Breakdown of academic impact, for papers by Liberata Sportiello Breakdown of academic impact, for papers by B.‐E. Wiholm Breakdown of academic impact, for papers by Harvey Newnham Breakdown of academic impact, for papers by Tiffany Peng
Rankless by CCL
2026